Merck & Co., Inc. news

   Watch this stock
Showing stories 1 - 10 of about 74   

Articles published

MRK 52.58 +0.05 (0.10%)
price chart
Merck, Pfizer Back Lawmakers Who Oppose Company Products
In addition to Johnson & Johnson, Phrma members Pfizer Inc., Bayer AG, and Merck & Co. Inc. sell birth-control products such as estrogen, IUDs or so-called morning after pills known as Plan B, according to IMS Health, a health-care information and ...
Merck Australia's Win in Vioxx Ruling Is Upheld by Court
May 11 (Bloomberg) -- Merck & Co. isn't liable in Australia for heart risks associated with the Vioxx painkiller, the country's top court ruled, upholding an appeal of the first trial decision outside the U.S.. Graeme Robert Peterson was awarded A$287 ...
Merck & Co. Partners with Trevena to Identify Biased GPCR Receptor Ligands
Merck & Co. is teaming up with Trevena on a research collaboration focused on exploiting the latter's technologies to screen for biased ligands against a specified receptor.
Merck investing $15M in Wilson facility
Pharmaceutical giant Merck & Co. Inc. announced a $15 million investment in two projects at its Wilson facility on Wednesday.
Merck Oncology Chief Heads to ASCO With High Hopes for New Drugs
At the annual conference of the American Society of Clinical Oncology (ASCO), starting tomorrow in Chicago, drug giant Merck will be presenting no less than 100 abstracts detailing its efforts to develop new cancer drugs. The company's oncology ...
Merck's Frazier Says He Won't Follow Pfizer in Splitting Company
May 31 (Bloomberg) -- Merck & Co. Chief Executive Officer Ken Frazier said he doesn't plan on breaking up the company by splitting off businesses the way Pfizer Inc. and Abbott Laboratories are doing. “My philosophy is fix what is broke, don't do the ...
RWJ Rahway honors Larry Naldi at gala
Larry Naldi, Hospital Board of Governors member and Merck & Co., Inc. Senior Vice President of Strategy and Integration, was inducted into the Guardians of the Rose at RWJ Rahway Foundation'€™s Rose Ball Gets Jazzed.
Top Female Trial Attorney: King & Spalding's Chilton Varner
Law360, New York (May 22, 2012, 7:21 PM ET) -- One day in early 1995, John Famularo was at his desk in the Lexington, Ky., office of Stites & Harbison PLLC, when his phone rang.
Roche Drug to Raise 'Good' Cholesterol Fails
Tim Anderson, a pharmaceutical analyst with Sanford C. Bernstein & Co., said Merck's drug could make it to market because it raises HDL and lowers LDL.
Roche Drops After Halting Cholesterol Drug Development  Bloomberg
Analytical Trend Troubles Scientists
Merck & Co. says its Fosamax—one of the most popular drugs in the class—has been prescribed 190 million times since first being approved in 1995.